Folliculin interacts with p0071 (plakophilin-4) and deficiency is associated with disordered rhoa signalling, epithelial polarization and cytokinesis

Human Molecular Genetics

Volumn 21, Issue 24, 2012, Pages 5268-5279

  Nahorski, Michael S ^a   Seabra, Laurence ^a   Straatman Iwanowska, Ania ^b   Wingenfeld, Aileen ^c   Reiman, Anne ^a   Lu, Xiaohong ^a   Klomp, Jeff A ^d   Teh, Bin T ^e   Hatzfeld, Mechthild ^c   Gissen, Paul ^b   Maher, Eamonn R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d VAN ANDEL RESEARCH INSTITUTE   (United States)

^e DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ESTRONE; PLAKOPHILIN; PLAKOPHILIN 4; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CELL JUNCTION; CELL MIGRATION; CYTOKINESIS; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOPRECIPITATION; KIDNEY COLLECTING TUBULE; KIDNEY TUBULE CELL; MITOSIS; MOUSE; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

CELL MOVEMENT; CYTOKINESIS; ESTRONE; HUMANS; IMMUNOPRECIPITATION; MICROSCOPY, FLUORESCENCE; PLAKOPHILINS; PROTEIN BINDING; REAL-TIME POLYMERASE CHAIN REACTION; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84870350030     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds378     Document Type: Article

References (41)

1. Menko, F.H., van Steensel, M.A., Giraud, S., Friis-Hansen, L., Richard, S., Ungari, S., Nordenskjold, M., Hansen, T.V., Solly, J. and Maher, E.R. (2009) Birt-Hogg-Dube syndrome: diagnosis and management. Lancet Oncol., 10, 1199-1206.
2. Toro, J.R., Wei, M.H., Glenn, G.M., Weinreich, M., Toure, O., Vocke, C., Turner, M., Choyke, P., Merino, M.J., Pinto, P.A. et al. (2008) BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports. J. Med. Genet., 45, 321-331.
3. Nahorski, M.S., Lim, D.H., Martin, L., Gille, J.J., McKay, K., Rehal, P.K., Ploeger, H.M., van Steensel, M., Tomlinson, I.P., Latif, F. et al. (2010) Investigation of the Birt-Hogg-Dube tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer. J. Med. Genet., 47, 385-390.
4. Rongioletti, F., Hazini, R., Gianotti, G. and Rebora, A. (1989) Fibrofolliculomas, tricodiscomas and acrochordons (Birt-Hogg-Dube) associated with intestinal polyposis. Clin. Exp. Dermatol., 14, 72-74.
5. Khoo, S.K., Giraud, S., Kahnoski, K., Chen, J., Motorna, O., Nickolov, R., Binet, O., Lambert, D., Friedel, J., Levy, R. et al. (2002) Clinical and genetic studies of Birt-Hogg-Dube syndrome. J. Med. Genet., 39, 906-912.
6. Nickerson, M.L., Warren, M.B., Toro, J.R., Matrosova, V., Glenn, G., Turner, M.L., Duray, P., Merino, M., Choyke, P., Pavlovich, C.P. et al. (2002) Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell, 2, 157-164.
7. Vocke, C.D., Yang, Y., Pavlovich, C.P., Schmidt, L.S., Nickerson, M.L., Torres-Cabala, C.A., Merino, M.J., Walther, M.M., Zbar, B. and Linehan, W.M. (2005) High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors. J. Natl Cancer Inst., 97, 931-935.
8. Woodward, E.R., Ricketts, C., Killick, P., Gad, S., Morris, M.R., Kavalier, F., Hodgson, S.V., Giraud, S., Bressac-de Paillerets, B., Chapman, C. et al. (2008) Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN. Clin. Cancer Res., 14, 5925-5930.
9. Painter, J.N., Tapanainen, H., Somer, M., Tukiainen, P. and Aittomaki, K. (2005) A 4-bp deletion in the Birt-Hogg-Dube gene (FLCN) causes dominantly inherited spontaneous pneumothorax. Am. J. Hum. Genet., 76, 522-527.
10. Baba, M., Hong, S.B., Sharma, N., Warren, M.B., Nickerson, M.L., Iwamatsu, A., Esposito, D., Gillette, W.K., Hopkins, R.F. III, Hartley, J.L. et al. (2006) Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc. Natl Acad. Sci. USA, 103, 15552-15557.
11. Hasumi, H., Baba, M., Hong, S.B., Hasumi, Y., Huang, Y., Yao, M., Valera, V.A., Linehan, W.M. and Schmidt, L.S. (2008) Identification and characterization of a novel folliculin-interacting protein FNIP2. Gene, 415, 60-67.
12. Chen, J., Futami, K., Petillo, D., Peng, J., Wang, P., Knol, J., Li, Y., Khoo, S.K., Huang, D., Qian, C.N. et al. (2008) Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS one, 3, e3581.
13. Baba, M., Furihata, M., Hong, S.B., Tessarollo, L., Haines, D.C., Southon, E., Patel, V., Igarashi, P., Alvord, W.G., Leighty, R. et al. (2008) Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J. Natl Cancer Inst., 100, 140-154.
14. van Slegtenhorst, M., Khabibullin, D., Hartman, T.R., Nicolas, E., Kruger, W.D. and Henske, E.P. (2007) The Birt-Hogg-Dube and tuberous sclerosis complex homologs have opposing roles in amino acid homeostasis in Schizosaccharomyces pombe. J. Biol. Chem., 282, 24583-24590.
15. Hudon, V., Sabourin, S., Dydensborg, A.B., Kottis, V., Ghazi, A., Paquet, M., Crosby, K., Pomerleau, V., Uetani, N. and Pause, A. (2010) Renal tumour suppressor function of the Birt-Hogg-Dube syndrome gene product folliculin. J. Med. Genet., 47, 182-189.
16. Hong, S.B., Oh, H., Valera, V.A., Stull, J., Ngo, D.T., Baba, M., Merino, M.J., Linehan, W.M. and Schmidt, L.S. (2010) Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling. Mol. Cancer, 9, 160.
17. Cash, T.P., Gruber, J.J., Hartman, T.R., Henske, E.P. and Simon, M.C. (2011) Loss of the Birt-Hogg-Dube tumor suppressor results in apoptotic resistance due to aberrant TGFbeta-mediated transcription. Oncogene, 30, 2534-2546.
18. Preston, R.S., Philp, A., Claessens, T., Gijezen, L., Dydensborg, A.B., Dunlop, E.A., Harper, K.T., Brinkhuizen, T., Menko, F.H., Davies, D.M. et al. (2011) Absence of the Birt-Hogg-Dube gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility. Oncogene, 30, 1159-1173.
19. Wolf, A., Keil, R., Gotzl, O., Mun, A., Schwarze, K., Lederer, M., Huttelmaier, S. and Hatzfeld, M. (2006) The armadillo protein p0071 regulates Rho signalling during cytokinesis. Nat. Cell Biol., 8, 1432-1440.
20. Chan, C.H., Lee, S.W., Li, C.F., Wang, J., Yang, W.L., Wu, C.Y., Wu, J., Nakayama, K.I., Kang, H.Y., Huang, H.Y. et al. (2010) Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis. Nat. Cell Biol., 12, 457-467.
21. Narumiya, S., Tanji, M. and Ishizaki, T. (2009) Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev., 28, 65-76.
22. Liu, S., Goldstein, R.H., Scepansky, E.M. and Rosenblatt, M. (2009) Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone. Cancer Res., 69, 8742-8751.
23. Hatzfeld, M. (2005) The p120 family of cell adhesion molecules. Eur. J. Cell Biol., 84, 205-214.
24. Hatzfeld, M., Green, K.J. and Sauter, H. (2003) Targeting of p0071 to desmosomes and adherens junctions is mediated by different protein domains. J. Cell Sci., 116, 1219-1233.
25. Hatzfeld, M. and Nachtsheim, C. (1996) Cloning and characterization of a new armadillo family member, p0071, associated with the junctional plaque: evidence for a subfamily of closely related proteins. J. Cell Sci., 109(Pt 11), 2767-2778.
26. Keil, R., Wolf, A., Huttelmaier, S. and Hatzfeld, M. (2007) Beyond regulation of cell adhesion: local control of RhoA at the cleavage furrow by the p0071 catenin. Cell Cycle, 6, 122-127.
27. Klomp, J.A., Petillo, D., Niemi, N.M., Dykema, K.J., Chen, J., Yang, X.J., Saaf, A., Zickert, P., Aly, M., Bergerheim, U. et al. (2010) Birt-Hogg-Dube renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression. BMC Med. Genomics, 3, 59.
28. Piekny, A., Werner, M. and Glotzer, M. (2005) Cytokinesis: welcome to the Rho zone. Trends Cell Biol., 15, 651-658.
29. Jaffe, A.B. and Hall, A. (2005) Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol., 21, 247-269.
30. Burridge, K. and Wennerberg, K. (2004) Rho and Rac take center stage. Cell, 116, 167-179.
31. Tervonen, T.A., Partanen, J.I., Saarikoski, S.T., Myllynen, M., Marques, E., Paasonen, K., Moilanen, A., Wohlfahrt, G., Kovanen, P.E. and Klefstrom, J. (2011) Faulty epithelial polarity genes and cancer. Adv. Cancer Res., 111, 97-161.
32. Watabe, M., Nagafuchi, A., Tsukita, S. and Takeichi, M. (1994) Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J. Cell Biol., 127, 247-256.
33. Tunggal, J.A., Helfrich, I., Schmitz, A., Schwarz, H., Gunzel, D., Fromm, M., Kemler, R., Krieg, T. and Niessen, C.M. (2005) E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. EMBO J., 24, 1146-1156.
34. Evans, A.J., Russell, R.C., Roche, O., Burry, T.N., Fish, J.E., Chow, V.W., Kim, W.Y., Saravanan, A., Maynard, M.A., Gervais, M.L. et al. (2007) VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Mol. Cell Biol., 27, 157-169.
35. Timpson, P., McGhee, E.J., Morton, J.P., von Kriegsheim, A., Schwarz, J.P., Karim, S.A., Doyle, B., Quinn, J.A., Carragher, N.O., Edward, M. et al. (2011) Spatial regulation of RhoA activity during pancreatic cancer cell invasion driven by mutant p53. Cancer Res., 71, 747-757.
36. Machacek, M., Hodgson, L., Welch, C., Elliott, H., Pertz, O., Nalbant, P., Abell, A., Johnson, G.L., Hahn, K.M. and Danuser, G. (2009) Coordination of Rho GTPase activities during cell protrusion. Nature, 461, 99-103.
37. Pavlovich, C.P., Grubb, R.L., Hurley, K., Glenn, G.M., Toro, J., Schmidt, L.S., Torres-Cabala, C., Merino, M.J., Zbar, B., Choyke, P. et al. (2005) Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome. J. Urol., 173, 1482-1486.
38. Wyckoff, J.B., Pinner, S.E., Gschmeissner, S., Condeelis, J.S. and Sahai, E. (2006) ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr. Biol., 16, 1515-1523.
39. Maxwell, P.H., Wiesener, M.S., Chang, G.W., Clifford, S.C., Vaux, E.C., Cockman, M.E., Wykoff, C.C., Pugh, C.W., Maher, E.R. and Ratcliffe, P.J. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 399, 271-275.
40. Nahorski, M.S., Reiman, A., Lim, D.H., Nookala, R.K., Seabra, L., Lu, X., Fenton, J., Boora, U., Nordenskjold, M., Latif, F. et al. (2011) Birt Hogg-Dube syndrome associated FLCN mutations disrupt protein stability. Hum. Mutat.
41. Lu, X., Wei, W., Fenton, J., Nahorski, M.S., Rabai, E., Reiman, A., Seabra, L., Nagy, Z., Latif, F. and Maher, E.R. (2011) Therapeutic targeting the loss of the birt-hogg-dube suppressor gene. Mol. Cancer Ther., 10, 80-89.